A Case of Bronchiectasis with High Serum CA19-9.
10.4046/trd.2008.64.5.383
- Author:
Jung Hun HUH
1
;
Su Mi LEE
;
Tae Hyoung KOO
;
Bong Chul SHIN
;
Soo Jung UM
;
Doo Kyung YANG
;
Soo Keol LEE
;
Choonhee SON
;
Mee Sook ROH
;
Ki Nam KIM
;
Ki Nam LEE
;
Pil Jo CHOI
Author Information
1. Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
- Publication Type:Case Report
- Keywords:
CA19-9;
Bronchiectasis;
Benign
- MeSH:
Biliary Tract Neoplasms;
Bronchiectasis;
Bronchiolitis;
Collagen;
Follow-Up Studies;
Gastrointestinal Diseases;
Haemophilus Infections;
Lung Diseases;
Pneumonia;
Positron-Emission Tomography;
Vascular Diseases
- From:Tuberculosis and Respiratory Diseases
2008;64(5):383-386
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
An elevated serum CA19-9 level is an indication of pancreatic and biliary tract cancer. However, it has recently become known that nonmalignant gastrointestinal diseases and a variety of nonmalignant respiratory diseases, such as idiopathic interstial pneumonia, collagen vascular disease associated lung diseases, diffuse panbronchiolitis and bronchiectasis, can also show an elevated serum CA19-9 level. We recently encountered a case of bronchiectasis with persistently elevated serum CA19-9, but without any evidence of malignant disease in endoscopic retrograde pancreatocholangiography, abdominal computed tomography, and positron emission tomography. After serial follow-up of 3 years and 10 months, there was still no evidence of cancer. It is believed that the elevated serum CA19-9 level was due to bronchiectasis. An elevated serum CA19-9 level should be interpreted carefully with the patients' clinical condition.
